| 1 | Jiangsu Hengrui Medicine Co., Ltd. | N/A | 8.89% | 975,728 |
| 2 | BeiGene, Ltd. | N/A | 7.46% | 343,518 |
| 3 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | N/A | 6.84% | 185,155 |
| 4 | WuXi Biologics (Cayman) Inc. | N/A | 6.46% | 1,781,635 |
| 5 | Innovent Biologics, Inc. | N/A | 4.52% | 533,500 |
| 6 | CSPC Pharmaceutical Group Limited | N/A | 4.19% | 4,286,889 |
| 7 | Akeso, Inc. | N/A | 3.89% | 300,000 |
| 8 | WuXi AppTec Co., Ltd. | N/A | 3.72% | 361,220 |
| 9 | Sino Biopharmaceutical Limited | N/A | 3.50% | 5,520,750 |
| 10 | Zhangzhou Pientzehuang Pharmaceutical., Ltd | N/A | 3.27% | 96,634 |
Get the Latest News and Ratings for KURE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. |
| 11 | Aier Eye Hospital Group Co., Ltd. | N/A | 3.06% | 1,471,663 |
| 12 | Shanghai United Imaging Healthcare Co., Ltd. | N/A | 2.98% | 132,661 |
| 13 | Yunnan Baiyao Group Co.,Ltd | N/A | 2.61% | 280,823 |
| 14 | Hansoh Pharmaceutical Group Company Limited | N/A | 2.39% | 618,000 |
| 15 | Sinopharm Group Co. Ltd. | N/A | 1.97% | 709,600 |
| 16 | Huadong Medicine Co., Ltd | N/A | 1.91% | 274,641 |
| 17 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | N/A | 1.85% | 165,142 |
| 18 | CSPC Innovation Pharmaceutical Co., Ltd. | N/A | 1.80% | 221,457 |
| 19 | Sichuan Kelun Pharmaceutical Co., Ltd. | N/A | 1.60% | 256,015 |
| 20 | WuXi AppTec Co., Ltd. | N/A | 1.58% | 155,984 |
| 21 | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | N/A | 1.42% | 207,647 |
| 22 | Beijing Tongrentang Co., Ltd | N/A | 1.35% | 219,190 |
| 23 | LEGN Legend Biotech | $28.60
-1.1% | 1.35% | 39,284 |
| 24 | Imeik Technology Development Co.,Ltd. | N/A | 1.33% | 46,840 |
| 25 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | N/A | 1.33% | 339,229 |
| 26 | Shanghai Pharmaceuticals Holding Co., Ltd | N/A | 1.33% | 439,212 |
| 27 | Chongqing Zhifei Biological Products Co., Ltd. | N/A | 1.20% | 375,472 |
| 28 | Shanghai RAAS Blood Products Co., Ltd. | N/A | 1.19% | 1,060,634 |
| 29 | Shenzhen New Industries Biomedical Engineering Co., Ltd. | N/A | 1.19% | 125,300 |
| 30 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | N/A | 1.19% | 169,465 |
| 31 | Shandong Weigao Group Medical Polymer Company Limited | N/A | 1.17% | 1,338,800 |
| 32 | Genscript Biotech Corporation | N/A | 1.11% | 628,000 |
| 33 | Changchun High-Tech Industry (Group) Co., Ltd. | N/A | 1.10% | 65,008 |
| 34 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | N/A | 1.01% | 228,550 |
| 35 | Beijing Tiantan Biological Products Co., Ltd. | N/A | 0.93% | 298,589 |
| 36 | Dong-E-E-Jiao Co.,Ltd. | N/A | 0.91% | 98,540 |
| 37 | Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | N/A | 0.91% | 150,810 |
| 38 | Pharmaron Beijing Co., Ltd. | N/A | 0.83% | 224,675 |
| 39 | Humanwell Healthcare (Group) Co.,Ltd. | N/A | 0.82% | 246,300 |
| 40 | Hualan Biological Engineering Inc. | N/A | 0.73% | 275,747 |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
| 41 | China Resources Pharmaceutical Group Limited | N/A | 0.72% | 938,500 |
| 42 | Hubei Jumpcan Pharmaceutical Co., Ltd. | N/A | 0.62% | 137,900 |
| 43 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. | N/A | 0.61% | 253,690 |
| 44 | Shanghai Pharmaceuticals Holding Co., Ltd | N/A | 0.59% | 345,300 |
| 45 | Hangzhou Tigermed Consulting Co., Ltd | N/A | 0.40% | 54,450 |
| 46 | Cash | N/A | 0.14% | 117,028 |
| 47 | Chinese Yuan Renminbi | N/A | 0.07% | 432,930 |
| 48 | Hong Kong Dollar | N/A | 0.00% | 472 |
| 49 | Kangmei Pharma - Rights O | N/A | 0.00% | 105,188 |
Buy KURE Stock Free KURE Stock Alerts